Spiegelman Daniel K

Spiegelman Daniel K is listed in filings as Director at Spruce Biosciences, Inc.. This profile follows SEC Form 4 activity through May 26, 2026, including 13 public disclosures. Recent filings connect the profile to Spruce Biosciences, Inc. (SPRB), Maze Therapeutics, Inc. (MAZE), vTv Therapeutics Inc. (VTVT), and Kyverna Therapeutics, Inc. (KYTX). The current snapshot covers public activity from Jun 27, 2024 to May 26, 2026. Reported amounts are shown as $89.6K to $100.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.